MiMedx Dodges Rival's $6.8M Trade Secret, Breach Suit
A Maryland federal judge has tossed claims brought by regenerative medicine company Osiris Therapeutics Inc. that its rival MiMedx Group Inc. breached a contract and stole trade secrets when the company...To view the full article, register now.
Already a subscriber? Click here to view full article